Our Team
Many Backgrounds. Different Perspectives. Persistently Curious.
MEET THE TEAM
ANTHONY CHIU, PhD
Associate
KARA MAKOWSKI
Total Rewards, Associate Director*
DANIEL BAHCHELI
Director, Research
BEAR ZHANG, PhD
Associate
AMANDA CREEDON
RAVen General Counsel
CHRIS GORGONE
Head of Capital Formation and Investor Relations
ANTHONY CHIU, PhD
Associate
Anthony Chiu is an Associate with the TechAtlas division of RA Capital Management. Anthony's primary responsibilities are to work closely with members of the investment team and portfolio companies to understand competitive landscapes, evaluate investment opportunities, and advise portfolio companies on program and pipeline strategy. Prior to RA, Anthony incubated new biotech ventures at Flagship Pioneering and consulted for biotech companies at McKinsey & Company. Anthony holds a BSc in Molecular Genetics from the University of Toronto and a PhD in Biology from MIT.
KARA MAKOWSKI
Total Rewards, Associate Director*
Kara serves as the Total Rewards, Associate Director for Raven and RA Capital Management. Kara is responsible for working across the firm's leadership to develop a comprehensive Total Rewards strategy, including managing our annual total rewards and compensation competitive analyses and finding new, innovative approaches to our Total Rewards program. Kara brings over 15 years of Human Resources experience. Before joining Raven, Kara was the Human Resources Manager at PSPDFKit where she was responsible for the provision of global human resources. Prior to PSPDFKit, she was the Senior Human Resources Manager at Intelerad Medical Systems where she facilitated the company’s growth from 60 to 350 employees; and led the HR integration process for five mergers and acquisitions. Her prior experience includes various leadership roles in Human Resources and Operations at Tiverton Advisors and Prometheus Group. Kara received her Bachelor of Science in Gerontology from the University of South Florida.
*Shared resource between RA Ventures and RA Capital.
DANIEL BAHCHELI
Director, Research
Daniel Bahcheli is an Director, Research at RA Capital Management. Daniel’s primary responsibility is to edit and guide development of competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. He worked previously as an Associate Managing Editor at EBSCO Health, and as a Medical Writer at IC Axon and Publicis Life Brands International. Daniel holds both a BS and MS degree in Microbiology and Immunology from McGill University.
BEAR ZHANG, PhD
Associate
Bear Zhang is an Associate with the TechAtlas division of RA Capital Management. Bear's primary responsibilities are to work closely with members of the investment team and portfolio companies to deeply understand competitive landscapes, evaluate investment opportunities in a variety of therapeutic areas across all stages from discovery and new company creation through commercialization, and advise portfolio companies on program and pipeline strategy. Prior to this role, he was a consultant at Clarion Healthcare. Bear holds a BSc in Biomedical Sciences from Zhejiang University and a PhD in Biological and Biomedical Sciences from Harvard University.
AMANDA CREEDON
RAVen General Counsel
Amanda Creedon is a Raven General Counsel at RA Capital Management. Her primary responsibilities are to counsel new companies on all their legal needs, advise on company formation, and assist RA Capital on private investments. Prior to RA, Amanda was a corporate associate at Wilson Sonsini Goodrich & Rosati, where she represented life sciences and technology companies throughout their business life cycle and counseled venture capital investors with respect to their investment transactions. Amanda holds a BA in Economics from Boston College and JD from Boston College Law School. Amanda is admitted to practice law in the Commonwealth of Massachusetts.
CHRIS GORGONE
Head of Capital Formation and Investor Relations
Chris Gorgone is a Head of Capital Formation and Investor Relations at RA Capital Management. His primary responsibility is to lead fundraising initiatives and client relations for the firm. He previously was at Quantum Capital Group, where he managed fundraising efforts across the firm's $25 billion suite of private market strategies including private equity, private credit, infrastructure, and venture capital. Prior to joining Quantum, Chris was a Managing Director with Man Group, where he was responsible for capital formation for the firm’s $175 billion alternatives platform. He advised some of the firm’s largest institutional clients on multi-alternatives portfolios as well as single strategies across hedge funds, private credit, and real assets, as well as traditional investment solutions. Previously, he was at Trian Partners, an activist equity fund managed by Nelson Peltz, and Balestra Capital, a discretionary global macro firm. In 2009, Chris worked for the U.S Department of the Treasury in Washington DC under the direction of Secretary Timothy F. Geithner on mortgage finance and TARP related initiatives. Prior to the Treasury, he was an Analyst at Lehman Brothers in its Fixed Income and Global Real Estate Group. Chrisholds a BA from Providence College and appears as a guest lecturer for both its MBA and undergraduate finance classes. He is Co-Founder of the school’s Wall Street Alumni Council and serves on the Business Advisory Council.